DalsnaFinance › IPOs › Zenas Biopharma Inc › IPO
Zenas BioPharma, Inc. completed its initial public offering on NASDAQ on September 13, 2024, pricing at $17.00 a share.
| Ticker | ZBIO |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 13, 2024 |
| Offering price | $17.00 |
| Shares offered | 13,235,294 |
| Total raised | $225M |
Zenas BioPharma, Inc. sold 13,235,294 shares at $17.00 each on NASDAQ. Multiplied out, that is $225 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $225 million total recorded for the deal.
Zenas BioPharma, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Zenas BioPharma, Inc.. This page is general information, not investment advice.